'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds
CNBC1 min read
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
Obesity assets represent about 25% of total forecast sales of the late-stage pipeline, while oncology's share has slipped to 20%, Deloitte found.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC